Skip to main content

Hovnanian Enterprises Reports Fourth Quarter and Fiscal Year 2025 Results

Met or Exceeded All Guidance Metrics Provided8% Year-Over-Year Increase in Consolidated CommunitiesSuccessfully Completed $900 Million Unsecured Debt Refinancing Extending Maturities Until 2031 and 2033Operating Performance Reflects a $34 Million Expense from Refinancing and $19 Million in Land Charges MATAWAN, N.J., Dec. 04, 2025 (GLOBE NEWSWIRE) — Hovnanian Enterprises, Inc. (NYSE: HOV), a leading national homebuilder, reported results for its fiscal fourth quarter and year ended October 31, 2025. RESULTS FOR THE THREE-MONTHS AND FULL YEAR ENDED OCTOBER 31, 2025:Total revenues were $817.9 million in the fourth quarter of fiscal 2025, which was within the guidance range we provided, compared with $979.6 million in the same quarter of the prior year. For the year ended October 31, 2025, total revenues were $2.98 billion compared...

Continue reading

MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress

Topline results from Phase 2 ZEPHYR trial of ML-007C-MA for schizophrenia expected in the second half of 2026 Topline results from Phase 2 VISTA trial of ML-007C-MA for Alzheimer’s disease psychosis expected in the second half of 2027 Raised $296.5 million in gross proceeds from initial public offering and concurrent private placement completed in October 2025 Cash, cash equivalents and short-term investments sufficient to fund operations through 2027SAN FRANCISCO and BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) — MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today reported financial results for the third quarter of 2025 and highlighted recent progress and upcoming milestones. “2025 was...

Continue reading

SAIC Announces Third Quarter of Fiscal Year 2026 Results

Revenues of $1.87 billion Net bookings of $2.2 billion; book-to-bill ratio and trailing twelve months book-to-bill ratio of 1.2 Year-to-date net bookings of $7.2 billion; year-to-date book-to-bill ratio of 1.3 Net income of $78 million; Adjusted EBITDA(1) of $185 million or 9.9% of revenues Diluted earnings per share of $1.69; Adjusted diluted earnings per share(1) of $2.58 Cash flows provided by operating activities of $129 million; Free cash flow(1) of $135 million Company increases fiscal year 2026 guidance on certain key metricsRESTON, Va., Dec. 04, 2025 (GLOBE NEWSWIRE) — Science Applications International Corporation (NASDAQ: SAIC), a premier Fortune 500 technology integrator driving our nation’s digital transformation across the defense, space, civilian, and intelligence markets, today announced results for the...

Continue reading

Half-year Financial Report

Albion Enterprise VCT PLCLEI Number : 213800OVSRDHRJBMO7204 December 2025 Albion Enterprise VCT PLC (the “Company”) Half-yearly Financial Report for the six months to 30 September 2025 Results announcementThe Company’s Directors are pleased to attach the Company’s Half-yearly Financial Report for the six months to 30 September 2025.  A summary of the information includes:Loss in the period of 0.64 pence per share (0.6% on opening net asset value) (30 September 2024: return of 8.51 pence per share) Net asset value of 112.72 pence per share (31 March 2025: 116.22 pence per share) £268.3 million fund size (30 September 2024: £145.7 million) Dividend paid of 2.91 pence per share in the period (30 September 2024: 3.14 pence per share)The Board declared a second dividend of 2.82 pence per share for the year ending...

Continue reading

UP Fintech Holding Limited Reports Unaudited Third Quarter 2025 Financial Results

SINGAPORE, Dec. 04, 2025 (GLOBE NEWSWIRE) — UP Fintech Holding Limited (NASDAQ: TIGR) (“UP Fintech” or the “Company”), a leading online brokerage firm focusing on global investors, today announced its unaudited financial results for the third quarter ended September 30, 2025. Mr. Wu Tianhua, Chairman and CEO of UP Fintech stated: “The market environment remained supportive in the third quarter. Our total revenues reached US$175.2 million, representing an increase of 73.3% year over year and 26.3% quarter over quarter. Commission income, interest income and other revenue all saw impressive growth both sequentially and year over year, each setting new record highs. By prioritizing user quality and product diversification, we have sustained a high ARPU that underpins our profitability and a healthy business model. As a result, both...

Continue reading

Vivoryon Therapeutics N.V. Reports Q3 2025 Financial Results and Business Updates

Vivoryon Therapeutics N.V. Reports Q3 2025 Financial Results and Business UpdatesNew analysis of data from varoglutamstat Phase 2 program for patients with lower baseline eGFR shows consistent and pronounced treatment effect, further supporting plans to advance development in stage 3b/4 DKD Compelling kidney function data from VIVIAD Phase 2b study presented in late-breaking poster session at ASN kidney week, the world’s premier nephrology meetingSuccessful completion of private placement supported by existing and new shareholders raising EUR 5.1 million; extends cash runway well into Q3 2026, providing financial runway and flexibility to realize strategic partnership Management to host conference call today at 3:00 pm CET (9:00 am EST)Halle (Saale) / Munich, Germany, December 4, 2025 – Vivoryon Therapeutics N.V. (Euronext...

Continue reading

Descartes Announces Fiscal 2026 Third Quarter Financial Results

Record Revenues and Income from Operations; Application Filed to Commence Normal Course Issuer Bid; CFO Transition Plan Outlined for Next Fiscal Year WATERLOO, Ontario and ATLANTA, Dec. 03, 2025 (GLOBE NEWSWIRE) — The Descartes Systems Group Inc. (TSX:DSG) (Nasdaq:DSGX) announced its financial results for its fiscal 2026 third quarter (Q3FY26). All financial results referenced are in United States (US) currency and, unless otherwise indicated, are determined in accordance with US Generally Accepted Accounting Principles (GAAP). “Our business performed ahead of our plans in Q3FY26, as we continue to add more solutions and content to our Global Logistics Network,” said Edward J. Ryan, Descartes’ CEO. “Our customers have faced continued tariff volatility, and heightened levels of changes to sanctioned and restricted...

Continue reading

Methode Electronics, Inc. Reports Fiscal 2026 Second Quarter Financial Results

Net sales of $246.9 million down 15.6% year-over-year; up 2.6% on a sequential quarter basis Net loss of $9.9 million or 4.0% of net sales; adjusted EBITDA margin of 7.1% Reaffirming fiscal 2026 guidance for net sales of $900 million to $1 billion and adjusted EBITDA of $70 to $80 millionCHICAGO, Dec. 03, 2025 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, lighting, and power distribution applications, today announced financial results for the second quarter of fiscal 2026 ended November 1, 2025. President and Chief Executive Officer Jon DeGaynor said, “Methode’s transformation journey made further progress in the quarter and is on track. I am proud of the unwavering commitment and hard work that the Methode team has put into our transformation....

Continue reading

Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update

–  Fourth quarter fiscal 2025 revenue up 5.9% to $138.1 million–  Fiscal 2025 revenue increased 4.5% to $513.0 million–  Fourth quarter fiscal 2025 operating loss decreased 48.5% to $6.8 million–  Fiscal 2025 operating loss decreased 64.2% to $30.9 million–  Conference call scheduled for today at 4:30 pm ET WEST LAFAYETTE, Ind., Dec. 03, 2025 (GLOBE NEWSWIRE) — Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months (“Q4 FY 2025”) ended September 30, 2025, and twelve months (“FY 2025”) ended September 30, 2025. Revenue by Segment (in millions of USD)    Three Months EndedSeptember 30,   %change...

Continue reading

nCino Reports Third Quarter Fiscal Year 2026 Financial Results

Total Revenues of $152.2M, up 10% year-over-year Subscription Revenues of $133.4M, up 11% year-over-year GAAP Operating Margin of 8%, up over 800 basis points year-over-year Non-GAAP Operating Margin of 26%, up 600 basis points year-over-yearWILMINGTON, N.C., Dec. 03, 2025 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced financial results for the third quarter of fiscal year 2026, ended October 31, 2025. “I’m extremely proud of our team’s strong execution in the third quarter, delivering results that exceeded expectations while advancing our AI leadership position,” said Sean Desmond, CEO at nCino. “The momentum we’re seeing across customer segments, geographies, and products reinforces our conviction in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.